Myriad Genetics (0K3W) Ratios
Myriad Genetics Ratios
GB:0K3W's free cash flow for Q2 2026 was $-10.40M. For the 2026 fiscal year, GB:0K3W's free cash flow was decreased by $-2.10M and operating cash flow was $-8.30M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.49 | 1.82 | 2.01 | 2.00 | 2.37 |
| Quick Ratio | 2.26 | 1.65 | 1.87 | 1.85 | 2.30 |
| Cash Ratio | 1.12 | 0.62 | 0.85 | 0.41 | 1.26 |
| Solvency Ratio | -0.92 | -0.20 | -0.55 | -0.19 | 0.10 |
| Operating Cash Flow Ratio | 0.01 | -0.05 | -0.71 | -0.77 | 0.09 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -7.54 | 1.43 |
| Net Current Asset Value | $ -6.00M | $ -28.50M | $ -49.70M | $ -38.30M | $ 131.90M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.14 | 0.13 | 0.12 | 0.07 |
| Debt-to-Equity Ratio | 0.57 | 0.20 | 0.19 | 0.16 | 0.10 |
| Debt-to-Capital Ratio | 0.36 | 0.17 | 0.16 | 0.14 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.25 | 0.05 | 0.05 | 0.13 | 0.08 |
| Financial Leverage Ratio | 1.92 | 1.47 | 1.46 | 1.35 | 1.36 |
| Debt Service Coverage Ratio | -28.73 | -22.61 | -68.45 | -3.24 | 2.15 |
| Interest Coverage Ratio | -6.46 | -44.11 | -88.76 | -43.94 | -28.86 |
| Debt to Market Cap | 0.21 | 0.03 | 0.02 | 0.12 | 0.04 |
| Interest Debt Per Share | 2.36 | 1.58 | 1.87 | 1.84 | 1.27 |
| Net Debt to EBITDA | -0.18 | -0.64 | -0.10 | -1.04 | -13.50 |
| Profitability Margins | |||||
| Gross Profit Margin | 69.93% | 69.89% | 68.64% | 70.22% | 71.39% |
| EBIT Margin | -46.65% | -14.41% | -34.43% | -20.25% | -7.31% |
| EBITDA Margin | -40.13% | -7.10% | -26.21% | -12.49% | 1.78% |
| Operating Profit Margin | -8.22% | -14.74% | -34.17% | -20.73% | -27.58% |
| Pretax Profit Margin | -47.92% | -14.74% | -34.81% | -20.73% | -8.27% |
| Net Profit Margin | -44.38% | -15.20% | -34.96% | -16.51% | -3.94% |
| Continuous Operations Profit Margin | -44.38% | -15.20% | -34.96% | -16.51% | -3.94% |
| Net Income Per EBT | 92.61% | 103.08% | 100.42% | 79.66% | 47.64% |
| EBT Per EBIT | 582.74% | 100.00% | 101.86% | 100.00% | 29.97% |
| Return on Assets (ROA) | -51.78% | -12.39% | -22.97% | -9.34% | -2.06% |
| Return on Equity (ROE) | -99.43% | -18.16% | -33.62% | -12.64% | -2.81% |
| Return on Capital Employed (ROCE) | -11.84% | -14.30% | -25.98% | -13.25% | -17.06% |
| Return on Invested Capital (ROIC) | -10.83% | -14.09% | -25.57% | -10.41% | -8.03% |
| Return on Tangible Assets | -72.95% | -26.58% | -51.67% | -21.04% | -4.02% |
| Earnings Yield | -63.77% | -10.25% | -16.61% | -9.58% | -1.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.15 | 6.91 | 6.59 | 6.68 | 7.56 |
| Payables Turnover | 8.26 | 7.81 | 9.16 | 7.01 | 6.68 |
| Inventory Turnover | 8.10 | 9.17 | 10.74 | 10.05 | 12.92 |
| Fixed Asset Turnover | 5.05 | 4.86 | 4.17 | 3.62 | 5.51 |
| Asset Turnover | 1.17 | 0.82 | 0.66 | 0.57 | 0.52 |
| Working Capital Turnover Ratio | 4.96 | 5.74 | 5.10 | 3.25 | 2.64 |
| Cash Conversion Cycle | 51.93 | 45.87 | 49.52 | 38.94 | 21.84 |
| Days of Sales Outstanding | 51.04 | 52.82 | 55.39 | 54.66 | 48.25 |
| Days of Inventory Outstanding | 45.05 | 39.80 | 34.00 | 36.32 | 28.26 |
| Days of Payables Outstanding | 44.17 | 46.75 | 39.87 | 52.04 | 54.68 |
| Operating Cycle | 96.10 | 92.61 | 89.39 | 90.98 | 76.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | -0.10 | -1.34 | -1.32 | 0.24 |
| Free Cash Flow Per Share | -0.27 | -0.42 | -2.22 | -1.88 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | 0.07 | -0.29 | -1.51 | -2.35 | 1.03 |
| Capital Expenditure Coverage Ratio | 0.07 | -0.29 | -1.51 | -2.35 | 1.03 |
| Operating Cash Flow Coverage Ratio | 0.01 | -0.06 | -0.73 | -0.73 | 0.20 |
| Operating Cash Flow to Sales Ratio | 0.00 | -0.01 | -0.15 | -0.16 | 0.03 |
| Free Cash Flow Yield | -4.46% | -3.09% | -11.62% | -12.97% | 0.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.55 | -9.72 | -6.02 | -10.44 | -78.86 |
| Price-to-Sales (P/S) Ratio | 0.70 | 1.48 | 2.10 | 1.72 | 3.11 |
| Price-to-Book (P/B) Ratio | 1.56 | 1.77 | 2.02 | 1.32 | 2.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -22.41 | -32.35 | -8.60 | -7.71 | 3574.86 |
| Price-to-Operating Cash Flow Ratio | 318.77 | -142.77 | -14.29 | -11.00 | 115.32 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.17 | -0.05 | -0.04 | 0.89 |
| Enterprise Value Multiple | -1.92 | -21.51 | -8.13 | -14.84 | 160.88 |
| Enterprise Value | 634.00M | 1.28B | 1.60B | 1.26B | 1.98B |
| EV to EBITDA | -1.92 | -21.51 | -8.13 | -14.84 | 160.88 |
| EV to Sales | 0.77 | 1.53 | 2.13 | 1.85 | 2.87 |
| EV to Free Cash Flow | -24.77 | -33.33 | -8.71 | -8.29 | 3298.02 |
| EV to Operating Cash Flow | 352.22 | -147.13 | -14.47 | -11.83 | 106.39 |
| Tangible Book Value Per Share | 1.75 | 1.68 | 1.77 | 2.72 | 4.18 |
| Shareholders’ Equity Per Share | 3.94 | 7.74 | 9.46 | 10.99 | 12.45 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.07 | -0.03 | -0.00 | 0.20 | 0.52 |
| Revenue Per Share | 8.84 | 9.25 | 9.10 | 8.42 | 8.89 |
| Net Income Per Share | -3.92 | -1.41 | -3.18 | -1.39 | -0.35 |
| Tax Burden | 0.93 | 1.03 | 1.00 | 0.80 | 0.48 |
| Interest Burden | 1.03 | 1.02 | 1.01 | 1.02 | 1.13 |
| Research & Development to Revenue | 0.13 | 0.14 | 0.12 | 0.13 | 0.12 |
| SG&A to Revenue | 0.65 | 0.67 | 0.38 | 0.37 | 0.78 |
| Stock-Based Compensation to Revenue | 0.04 | 0.06 | 0.05 | 0.06 | 0.05 |
| Income Quality | -0.00 | 0.07 | 0.42 | 0.95 | -0.68 |
Currency in USD
